AN EVIDENCE AND RISK-BASED APPROACH TO A HARMONISED LABORATORY ALERT LIST. RCPA-AACB Working Party for High Risk result Management
|
|
- Joy Todd
- 5 years ago
- Views:
Transcription
1 AN EVIDENCE AND RISK-BASED APPROACH TO A HARMONISED LABORATORY ALERT LIST RCPA-AACB Working Party for High Risk result Management
2 RCPA-AACB WORKING PARTY FOR HIGH RISKS RESULTS Craig Campbell Grahame Caldwell Penelope Coates Robert Flatman Andrew Georgiou Rita Horvath Que Lam Alan McNeil Hans Schneider
3 PROCESS FOR DECIDING THE ALERT THRESHOLDS The working party has designed a 6 step process for deciding alert thresholds. Process considers Evidence for thresholds Risk to patient - if no action taken Analytical aspects Workload implications
4 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence Low threshold 2.5 or 2.8 mmol/l? High threshold strong case for 6.2 mmol/l LOW K THRESHOLD Level 1 - Clinical Outcome Studies Level 2 - Recommended by Professional Bodies Laboratories and Clinicians Clinicians Laboratories 2.5 ( ) [3] 2.8 ( ) [3] Level 3 - Surveys 2.5 ( ) [1] 2.8 ( ) [11] Level 4 - Individual Institutions 2.75 ( ) [12] 2.5 ( ) [7] 2.8 ( ) [21] Limitations of Evidence Evidence mainly state of the art Search only retrieved evidence where laboratory terminology was used (i.e., critical results, panic values, etc). HIGH K THRESHOLD Level 1 - Clinical Outcome Studies Level 2 - Recommended by Professional Bodies Laboratories and Clinicians Clinicians Laboratories 6.2 ( ) [1] 6.3 ( ) [1] 7.0 ( ) [1] 6.2 ( ) [3] 6.2 ( ) [3] Level 3 - Surveys 6.0 ( ) [1] 6.2 ( ) [11] Level 4 - Individual Institutions 6.25 ( ) [12] 6.0 ( ) [7] 6.05 ( ) [22]
5 Retrospective can t select comparison groups K measurement and mortality - not subjective 48 hour/in-hospital/ 1 year mortality High K - cause or consequence? Mortality at different concentrations Big data needed for odds ratios with confidence intervals
6 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence - Results sorted into groups. - Group 1 = comparator. ~ Based on 873,000 test results Significant increase in risk of in-hospital mortality Significant decrease in risk of in-hospital mortality
7 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ Based on 873,000 test results Plots of 48-hour survival from first potassium measurement. Authors Conclusion 6.2 mmol/l appropriate for upper threshold. 2.8 mmol/l not conservative enough for lower threshold.
8 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ 6,600 hyperkalaemic patients over 5 years High mortality rate Number of patients with k > 6.3 Review of every death within 8hrs of K > 6.3: hk was cause of death in very few cases High in-hospital mortality rate for patients with a hyperkalaemia discharge diagnosis code. Hyperkalaemia was judged to be responsible for only 4 deaths throughout 5 year period.
9 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ 186 patients with potassium > 6.0 mmol/l. 14% mortality (16/111) in patients with K between 6 and 7 mmol/l. Absence of or early ECG changes in K between 6 and 7 mmol/l.
10 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence Working party decided that we need to also perform more targeted searches for Level 1 evidence. PubMed Search Keywords: hypokalemia, hyperkalemia, mortality.
11 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ 923 patients with potassium > 6.5 mmol/l. High in-hospital mortality rate Mortality significantly associated with: severe underlying disease coexisting medical conditions severe hyperkalemia The comparator (AKI without CKD) was a strong predictor of mortality. Results imply that CKD protects against mortality caused by hyperkalaemia.
12 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ 38,000 patients with potassium > 4.0 mmol/l. Associations adjusted for: age, race, gender, WBC, HCO3, BUN, creatinine, glucose, Deyo-Charlson Index, transfusions, patient type (medical versus surgical), sepsis, RRT, AKI, diabetes mellitus Significant increase in risk of inhospital mortality at K > 4.5 mmol/l.?? Odds ratios not rising when K goes above 5.5 mmol/l. Risk of mortality was negated in patients whose K declined by >1 mmol/l within 48 hrs of critical care initiation. ~ Effective Treatment
13 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ 6,000 patients who died within 1 day of a blood draw for potassium. As severity of CKD increases, the risk of mortality (within 1 day of a hyperkalaemic event) reduces.?? Should we have a higher alert threshold for advanced CKD??
14 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ 15,500 patients. Mortality follow-up: 23.5 years (on average). Why no long term mortality risk in diuretic-induced hypokalaemia? Perhaps an underlying disease (such as chronic illness or hyperaldosteronism) is the causal risk factor.
15 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ 2,100 patients. Mortality follow-up: 8 years. Significantly increased risk of long term CVD mortality for K 3.5 to 3.8 mmol/l (low normal) compared to K 3.9 to 4.4 mmol/l (high normal). No increase in risk of long term CVD mortality for K 2.8 to 3.4 mmol/l (low) compared to K 3.5 to 3.8 mmol/l (low normal).
16 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence ~ 375 patients. In-hospital mortality. Very high mortality rate for severe hypokalaemia. 80% (32/40) of patients that died with severe hypokalaemia also had hypernatraemia. Was the hypernatremia responsible for mortality?
17 DECIDING POTASSIUM ALERT THRESHOLDS Steps 1 and 2 Review Literature / Rate Evidence What can we take from the literature review? Note that outcome studies were mainly retrospective: Labs still phoned critical potassiums Patients were treated for potassium imbalances as per normal No evidence to suggest that state of the art upper threshold (of 6.2 mmol/l) requires adjusting (based on cardiac related mortality). Based on limited evidence, hypokalemia (down to 2.5 mmol/l) may have a casual rather than causal relationship with the high rate of mortality. Insufficient evidence to justify the lower threshold of 2.5 mmol/l.
18 DECIDING POTASSIUM ALERT THRESHOLDS Steps 3 Risk Analysis 1. Identify potential harm and clinical intervention 2. Estimate likelihood and severity of potential harm, and urgency of clinical intervention 3. Evaluate whether routine reporting exposes patient to unacceptable risk
19 DECIDING POTASSIUM ALERT THRESHOLDS Steps 3 Risk Analysis Where can we get information on clinical intervention? Guideline Search: GIN (Guidelines International Network) The US National Guideline Clearing House etg (Electronic Therapeutic Guidelines, Australia) Online clinician decision support systems: BMJ Best Practice UpToDate PubMed Search: Keywords - (Hypokalemia OR Hyperkalemia OR Potassium) AND Guideline
20 DECIDING POTASSIUM ALERT THRESHOLDS Steps 3 Risk Analysis Hyperkalaemia - Essentially 3 Levels of Treatment 1. Calcium gluconate: Immediately administered to patients with symptoms or ECG changes ~ to stabilise the cardiac muscle. (Temporary effect) 2. Insulin and beta-2 agonists: Urgently administered to patients with symptoms, ECG changes, or moderate to severe hyperkalemia ~ to shift the potassium from the plasma to the cells. (Temporary effect) 3. Loop diuretics, ion-exchange resin, or dialysis: Urgency depends on severity and acuteness of hyperkalaemia; Administered to patients with severe, moderate or possibly mild hyperkalaemia ~ to eliminate excess potassium. (Permanent effect) Critical Risk
21 DECIDING POTASSIUM ALERT THRESHOLDS Steps 3 Risk Analysis Definitions for Severity of Hyperkalaemia 6.2 mmol/l is middle ground between 6.0 and 6.5 mmol/l What constitutes mild, moderate and severe hyperkalaemia is inconsistently defined in the literature. Source Sample Type Mild Hyperkalaemia Moderate Hyperkalaemia Severe Hyperkalaemia Emergency Treatment etg Australia Serum ECG helps determine urgency BMJ Best Practice Serum mmol/l UpToDate (Adult) Serum > 5.5 mmol/l > 6.5 mmol/l > 6.5 mmol/l UpToDate (Children) Serum or Plasma > 7.0 mmol/l > 7.0 mmol/l Emerg Med Pract Feb;14(2):1-17 Pharmacol Res Nov;113(Pt A): J Manag Care Spec Pharm Apr;23(4-a Suppl):S10- S19. Resuscitation 46 (2000) Am Fam Physician Sep 15;92(6): Serum mmol/l mmol/l > 7.5 mmol/l Insulin at > 6.5 mmol/l Serum Serum Serum > 5.0 mmol/l > 6.0 mmol/l > 7.0 mmol/l Serum > 6.5 mmol/l Ca at > 6.5 mmol/l; B2 agonist/insulin at > 6.0 mmol/l. Insulin/albuterol at > 6.0 mmol/l Insulin/albuterol/bicarb at > 6.0 mmol/l Prompt intervention at > 6.5 mmol/l
22 DECIDING POTASSIUM ALERT THRESHOLDS Steps 3 Risk Analysis Hypokalaemia Definitions and Treatment Definitions for severity of hypokalaemia are more consistent in the literature: Mild ~ < 3.5 mmol/l Moderate ~ < 3.0 mmol/l Severe ~ < 2.5 mmol/l Urgent treatment: IV administration of K with constant ECG monitoring Required in patients with symptoms or ECG changes Opinion varies on whether severe asymptomatic hypokalaemia requires urgent treatment Non-urgent treatment is typically an oral dose of K once daily.
23 DECIDING POTASSIUM ALERT THRESHOLDS Steps 3 Risk Analysis Conclusions Considering state of the art, mortality study findings and urgency of treatment, the critical risk alert thresholds for K should be: < 2.5 mmol/l AND > 6.2 mmol/l Laboratories should also monitor for sudden shifts in K levels away from the reference interval. More conservative significant risk thresholds may be needed for community based patients to enable earlier detection of acute hypo/hyperkalaemia.
24 K+ THRESHOLDS SO FAR K+ <2.5 mmol/l K+ >6.2 mmol/l
25 4. ASSESS TRANSFERABILITY AND CONSIDER THE PRE- AND POSTANALYTICAL ASPECTS OF THE ALERT THRESHOLD
26 POPULATION SPECIFIC ALERT THRESHOLDS PATIENTS ON DIALYSIS Should they have a higher hyperkalemia threshold? Can they be reliably identified? Not supported by clinical experience NEONATES & INFANTS Low renal excretion of potassium in first few months life AACB CRI 0-1 wk URL 6.5 mmol/l 2-26 wk URL 6.7 mmol/l UK NHS Neonatal Guidelines: Rx at K+> 7.0 mmol/l (& more aggressive Rx when >7.5 mmol/l) K+ Threshold >7.0 mmol/l for infants 0-6 months.
27 PREANALYTICAL CONSIDERATIONS EFFECT OF SAMPLE TYPE Plasma vs. serum Assumption that studies looking at K+ probably contained a mixture of specimen types. AACB CRI already accepts the mmol/l difference between serum and plasma. For adults, K+ 6.2 mmol/l serum ; 5.9 mmol/l plasma K+ 6.2 mmol/l plasma; 6.5 mmol/l serum For infants, Where plasma is preferred specimen, could reasonably lower threshold from 7.0mmol/L to 6.5 mmol/l
28 PSEUDOHYPERKALAEMIA Delayed separation is a significant issue for some laboratories.?any idea of magnitude of problem Approaches: Choose a higher threshold to accommodate these higher potassiums not recommended Assess potassium result on individual basis Ignore the issue H = 261 = 5.3% L = 165 = 3.4%
29 5. ASSESS THE IMPACT OF THE SELECTED THRESHOLDS ON THE FREQUENCY OF CRITICAL ALERTS
30 FLAGGING RATES Should not determine which threshold to use. However, where evidence is not strong, may provide useful information. Indicate the burden of notification. Absolute no. calls vs. % total. Degree of difficulty Outpatient vs. Inpatient notification Time of day notification is made Limitations of modelling Need data over a long time period. Need paediatric results to assess specific threshold. Need to assess all notifiable test results, not just one test in isolation.
31 K+ FLAGGING DATA Reported K+ results Mon 5 th Sun 11 th March. Public Hospital Laboratory 2 public hospitals n= 4906 (outpt:inpt 1:4) Private Pathology network 32 laboratories n = (outpt:inpt 7:3) Pathology Services asked to look at flagging rates and no. of actual calls (keeping with local instructions).
32 POTASSIUM FLAGGING RATE Hypokalemia < 2.5 mmol/l - guidelines < 2.8 mmol/l state of the art < 3.0 mmol/l - guidelines < 3.5 mmol/l significant risk Hyperkalemia > 5.5 mmol/l significant risk > 6.0 mmol/l guidelines > 6.2 mmol/l state of the art > 6.5 mmol/l - guidelines > 7.0 mmol/l paediatric*, and level at which ECG changes are more likely
33 HYPOKALEMIA K Threshold (mmol/l) Results flagged Abs. Calls Av. Calls per day. No. lab Highest burden lab Abs calls /day (total call/week) Inpt:Outpt <2.5 <2.8 <3.0 <3.5 1 (0.02%) (0) 0:0 1 (0.00 %) (0) 1:0 6 (0.12%) (5) 3:2 6 (0.00%) (1) 1:3 18 (0.37%) (15) 11:4 28 (0.00%) (6) 14:6 165 ( 3.4%) (141) 118: (2.14%) (109) 148:170
34 HYPERKALEMIA K Threshold (mmol/l) Results flagged Abs. Calls Av. Calls per day. No. lab Highest burden lab Abs calls /day (total call/week) >7.0 1 (0.02%) (1) 1:0 6 (0.00%) (1) 2:1 >6.5 1 (0.02%) (1) 4:1 15 (0.00%) (3) 5:2 > (0.34%) (15) 13:2 23 (0.01%) (7) 8:5 > (0.57%) (25) 20:5 Inpt:Outpt 46 (0.01%) (16) 17:13 > (2.3%) (99) 68: (0.07%) (87) 76:100
35 K+ THRESHOLDS SO FAR K+ <2.5 mmol/l? <3.0 mmol/l? K+ >6.2 mmol/l? >6.0 mmol/l? Paediatric: >7.0 mmol/l serum + plasma? >6.5 mmol/l plasma?
36 6. SEEK ENDORSEMENT FOR SELECTED THRESHOLDS FROM LABORATORIES AND CLINICAL GROUPS
37 ENDORSEMENT Laboratories Thresholds will be circulated for comment through AACB. Individual labs model flagging rate and compare to current thresholds. Clinicians Clinical groups medical colleges, representative societies/organisations. Indivdual labs consult their clinicians local guidelines survey ;?statewide?australasian
38 Survey of clinicians from all hospitals serviced by NSW Health Pathology laboratories (130 clinicians from 34 hospitals. 74% consultants). Online questionnaire Respondents were asked: whether they agreed with the thresholds in the list. If not, nominate alternate thresholds. The timeframe (immediately, within 8 hours or by the next business day) in which each of the critical risk results should be phoned.
39 Test Age Laboratory Threshold Clinician Agreement with Lab Threshold Clinician Proposed Alternate Threshold [if disagreed with lab] Mean (Range) [n] Immediate Phoning Required < 2.8 mmol/l 90.5% (86/95) 2.8 ( ) [9] 82.1% (69/84) Potassium 0 to < 28 days > 7.0 mmol/l 82.7% (81/98) 6.3 ( ) [14] 97.7% (84/86) PAEDIATRIC THESHOLDS For patients aged 0 to 1 month, 79% of survey respondents (53/67) agree with an upper alert threshold of >7.0 mmol/l. Among those that disagree, 6 have proposed a threshold of >6.2 mmol/l, while 4 suggested >6.5 mmol/l.
40 Test Age Laboratory Threshold Clinician Agreement with Lab Threshold Clinician Proposed Alternate Threshold [if disagreed with lab] Mean (Range) [n] Immediate Phoning Required Potassium 28 days to < 110 years < 2.5 mmol/l 89.8% (106/118) 2.9 ( ) [13] 83.8% (88/105) > 6.2 mmol/l 74.2% (89/120) 6.3 ( ) [33] 82.4% (84/102) ADULT THRESHOLDS For patients aged 28 days to 110 years, there was 71% agreement (57/79) for a threshold of >6.2 mmol/l. Alternative thresholds proposed by respondents for this age group include >6.0 mmol/l (9 respondents) and >6.5 mmol/l (9 respondents). What are the actionable thresholds? Is it preferable to be warned before the actionable level?
41 CONCLUSIONS POTASSIUM THRESHOLDS K+ <2.5 mmol/l? <2.8 mmol/l? <3.0 mmol/l? K+ >6.2 mmol/l? >6.0 mmol/l? >6.5 mmol/l? Paediatric: >7.0 mmol/l serum + plasma? >6.5 mmol/l plasma?
42 CONCLUSIONS - PROCESS 6 step process Hyperkalemia and hypokalemia as a example. Each step requires a lot of work. Plan to limit the number of thresholds we attempt Pros: less work, shorter timeframe Cons: Critical results fatigue (labs and clinicians).
43
44 POTASSIUM RESULTS MON 5 TH SUN 11 TH MARCH. PUBLIC HOSPITAL LABORATORY SERVICING 2 HOSPITALS. N=4906 H = 261 = 5.3% L = 165 = 3.4% More
45 No. of phone calls No. of phone calls POTASSIUM RESULTS MON 5 TH SUN 11 TH MARCH. PUBLIC HOSPITAL LABORATORY SERVICING 2 HOSPITALS. N=4906 K Threshold (mmol/l) > 7.0 >6.5 >6.2 paediatric, and level at which ECG changes are more likely guidelines state of the art Results flagged Calls Mad e Av. Calls per day. 1 (0.02%) :0 7 (0.14%) :1 17 (0.34%) :2 > (0.45%) :2 >6.0 Guidelines 28 (0.57%) :5 > (0.73%) :8 >5.5 significant risk Inpt:Outpt 112 (2.3%) : MON TUES WED THUR FRI SAT SUN
Breakout Session C: Harmonisation of the Alert Table.
Breakout Session C: Harmonisation of the Alert Table. RCPA-AACB High Risk Results Working Party Andrew Georgiou Craig Campbell Grahame Caldwell Hans Schneider Penelope Coates Que Lam Rita Horvath Robert
More informationWhat tests should be on the Alert List?
What tests should be on the Alert List? Dr Que Lam On behalf RCPA-AACB High Risk Results Working Party: Alan McNeil, Grahame Caldwell, Craig Campbell, Penelope Coates, Robert Flatman, Andrew Georgiou,
More informationBreakout Session C: Harmonisation of the Alert Table.
Breakout Session C: Harmonisation of the Alert Table. RCPA-AACB High Results Working Party Andrew Georgiou Craig Campbell Grahame Caldwell Hans Schneider Penelope Coates Que Lam Rita Horvath Robert Flatman
More informationElectrolyte Imbalance and Resuscitation. Dr. Mehmet Okumuş Sütçü Imam University Faculty of Medicine Department of Emergency Medicine
Electrolyte Imbalance and Resuscitation Dr. Mehmet Okumuş Sütçü Imam University Faculty of Medicine Department of Emergency Medicine Presentation plan Definition of the electrolyte disturbances Conditions
More informationQuality Initiative In Pathology. Harmonisation of Laboratory Testing
Quality Initiative In Pathology Harmonisation of Laboratory Testing Harmonisation: what do we mean? Agreement of test results irrespective of the method used or the testing laboratory Requires: Common
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationPRODUCT INFORMATION RESONIUM A. Na m
PRODUCT INFORMATION RESONIUM A NAME OF THE MEDICINE Non-proprietary Name Sodium polystyrene sulfonate Chemical Structure CH - 2 CH SO 3 Na + n CAS Number 28210-41-5 [9003-59-2] CH 2 CH SO - 3 m DESCRIPTION
More informationPaediatric Nephrology Date of submission March 2014
Hyperkalaemia Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Guideline for the assessment and management of hyperkalaemia
More informationLogbook Dates FROM TO
LOGBOOK Logbook Dates FROM TO Contact Details NAME ADDRESS CITY STATE / POSTCODE PHONE DOCTOR S NAME DOCTOR S PHONE DOCTOR S EMAIL DIABETES EDUCATOR S NAME DIABETES EDUCATOR S PHONE DIABETES EDUCATOR S
More informationPP-US-DSE Relypsa, Inc. All rights reserved. Relypsa and the Relypsa logo are trademarks of Relypsa, Inc.
1 2 There are 4 main objectives that I d like to cover with you today: First, to review the definition, prevalence, and risk of hyperkalemia in certain populations Second, to review why RAASi are recommended
More informationCRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018
CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018 Case 1 Potassium Clearance A 70 kg male is placed on CVVH with a total ultrafiltration rate (effluent rate) of 20 ml/kg/hr. The Blood Flow
More informationCRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018
CRRT Interactive Hyperkalemia Cases AKI & CRRT conference 2018 Case 1 Potassium Clearance A 70 kg male is placed on CVVH with a total ultrafiltration rate (effluent rate) of 20 ml/kg/hr. The Blood Flow
More informationStandardizing Detection of Acute Kidney Injury in an Integrated Delivery Health System
Standardizing Detection of Acute Kidney Injury in an Integrated Delivery Health System Tarush Kothari, MD, MPH Physician Informaticist, Northwell Health Laboratories Assistant Professor in Pathology and
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Hyperkalaemia
Southern Derbyshire Shared Care Pathology Guidelines Hyperkalaemia Purpose of Guideline Dealing with adult patients with Hyperkalaemia in the community Definition Serum potassium normal range is 3.5 5.3
More informationAUSTRALIAN PATHOLOGY UNITS AND TERMINOLOGY (APUTS) Harmonised Reference Intervals Chemical Pathology. (v1.1)
AUSTRALIAN PATHOLOGY UNITS AND TERMINOLOGY (APUTS) Harmonised Reference Intervals Chemical Pathology (v1.1) ISBN: Pending 1 State Health Publication Number (SHPN): Pending Online copyright RCPA 2014 This
More informationCCRN Review - Renal. CCRN Review - Renal 10/16/2014. CCRN Review Renal. Sodium Critical Value < 120 meq/l > 160 meq/l
CCRN Review Renal Leanna R. Miller, RN, MN, CCRN-CMC, PCCN-CSC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Sodium 136-145 Critical Value < 120 meq/l > 160 meq/l Sodium Etiology
More informationReference Intervals. Graham Jones / Gus Koerbin
Reference Intervals Graham Jones / Gus Koerbin Adult CRI - Harmonisation Harmonisation 1 2012: (13 tests + 1 calculation) Harmonisation 2 2013: Confirm 2012 recommendations. Discussed: albumin, globulin,
More informationTumour Lysis Syndrome (TLS)
(TLS) Overview: Tumour lysis syndrome refers to a number of metabolic disturbances (hyperuricaemia, hyperphosphataemia, hyperkalaemia and hypocalcaemia) that occur as the result of rapid cell lysis. This
More informationELECTROLYTES RENAL SHO TEACHING
ELECTROLYTES RENAL SHO TEACHING Metabolic Alkalosis 2 factors are responsible for generation and maintenance of metabolic alkalosis this includes a process that raises serum bicarbonate and a process that
More informationCKD and risk management : NICE guideline
CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of
More informationAcute Kidney Injury in the ED
+ Acute Kidney Injury in the ED + Dr Eric Clark, MD FRCPC University of Ottawa Canada Canadian Association of Emergency Physicians + Outline 1. Diagnostic challenges 2. ED treatment 3. Contrast induced
More informationFor People With Diabetes. Blood Sugar Diary. SCAN Health Plan
For People With Diabetes Blood Sugar Diary SCAN Health Plan 78 A Circle of Help to Live a Healthy Life You are the center of a healthy life with diabetes. All the elements of good care begin and end with
More informationPhlebotomy Top Gun Order of Draw: Do We Still Care?
Phlebotomy Top Gun Order of Draw: Do We Still Care? 2018 MFMER 3793435-1 Presenter: Brad Karon, M.D., Ph.D. Professor of Laboratory Medicine and Pathology Division of Clinical Core Laboratory Services
More informationA Mnemonic for the Treatment of Hyperkalemia. Nick Wolters, PGY1 Resident Grandview Medical Center
A Mnemonic for the Treatment of Hyperkalemia Nick Wolters, PGY1 Resident Grandview Medical Center Hyperkalemia 30 YOF, ESRD, missed 2 dialysis sessions over the last week Potassium level came back at 7
More informationWATER, SODIUM AND POTASSIUM
WATER, SODIUM AND POTASSIUM Attila Miseta Tamás Kőszegi Department of Laboratory Medicine, 2016 1 Average daily water intake and output of a normal adult 2 Approximate contributions to plasma osmolality
More informationMedical therapy of AKI complications. Refik Gökmen AKI Academy 18 October 2014
Medical therapy of AKI complications Refik Gökmen AKI Academy 18 October 2014 Medical therapy of AKI complications Hyperkalaemia Volume status, fluid therapy Acidosis Calcium & phosphate Bleeding risk
More informationHyponatremia and Hypokalemia
Hyponatremia and Hypokalemia Critical Care in the ED March 21 st, 2019 Hannah Ferenchick, MD 1 No financial disclosures 2 1 Outline: 1. Hyponatremia Diagnosis Initial treatment 2. Hyperkalemia Diagnosis
More informationREFERRAL GUIDELINES: RENAL MEDICINE
Outpatient Page 1 1 REFERRAL GUIDELINES: RENAL MEDICINE Demographic Clinical Date of birth Reason for referral Contact details (including mobile phone) Duration of symptoms Essential Referring GP details
More informationManagement of Acute Kidney Injury in the Neonate. Carolyn Abitbol, M.D. University of Miami Miller School of Medicine / Holtz Children s Hospital
Management of Acute Kidney Injury in the Neonate Carolyn Abitbol, M.D. University of Miami Miller School of Medicine / Holtz Children s Hospital Objectives Summarize the dilemmas in diagnosing & recognizing
More informationThe order of draw - myth or science? Dr Mike Cornes: Principal Clinical Scientist Royal Wolverhampton NHS Trust
The order of draw - myth or science? Dr Mike Cornes: Principal Clinical Scientist Royal Wolverhampton NHS Trust Where is Wolverhampton? Samples Errors Where is Order of draw Important? Problems Associated
More informationWEEK. MPharm Programme. Acute Kidney Injury. Alan M. Green MPHM13: Acute Kidney Injury. Slide 1 of 47
MPharm Programme Acute Kidney Injury Alan M. Green 2017 Slide 1 of 47 Overview Renal Function What is it? Why does it matter? What causes it? Who is at risk? What can we (Pharmacists) do? How do you recognise
More informationDISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE
ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationA case of nonfatal non-collapsed patient with extreme hyperkalaemia
Hong Kong Journal of Emergency Medicine A case of nonfatal non-collapsed patient with extreme hyperkalaemia YH Lim and J Hendricks This is a report of a non-collapsed patient with nonfatal, extreme hyperkalaemia
More informationDiabetes in Renal Patients. Contents. Understanding Diabetic Nephropathy
Diabetes in Renal Patients Contents Understanding Diabetic Nephropathy What effect does CKD have on a patient s diabetic control? Diabetic Drugs in CKD and Dialysis Patients Hyper and Hypoglycaemia in
More informationUtilizing Automated Adverse Event Detection
Utilizing Automated Adverse Event Detection David C Stockwell, MD, MBA Executive Director of Improvement Science Medical Director of Patient Safety and Pediatric ICU Children s National Medical Center
More informationResuscitation of the Critically ill Foal
Resuscitation of the Critically ill Foal Sick Cell Syndrome Foal: Wishful Warm Blood filly DOB: March 25 1 AM Admission Date: March 25 11:25 AM 10 hours old Wishful History Born at 1 AM on March 25 Foal
More informationA case of severe hyperkalaemia presenting with cardiac arrythmias: An uncommon initial manifestation of chronic kidney disease
Case Report A case of severe hyperkalaemia presenting with cardiac arrythmias: An uncommon initial manifestation of chronic kidney disease D H Sudusinghe 1, J indrakumar 2 1 Department of Physiology, Faculty
More informationApplying clinical guidelines treating and managing CKD
Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012
More informationATHLETE START UP QUESTIONNAIRE The first step in the coaching process is filling out the athlete questionnaire. Once completed, back to me.
ATHLETE START UP QUESTIONNAIRE The first step in the coaching process is filling out the athlete questionnaire. Once completed, email back to me. General/Medical 1. Name 2. Address 3. E-mail 4. Phone Best
More informationMANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION
Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals
More informationkeyword: diuretics Drug monitoring Monitoring diuretics in primary care 2 March 2009 best tests
www.bpac.org.nz keyword: diuretics Drug monitoring Monitoring diuretics in primary care 2 March 2009 best tests Why do we monitor patients taking diuretics and what do we monitor? Monitoring a person on
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationUpdate in Hypertension
Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded
More informationNephrology / Urology. Hyperkalemia Causes and Definition Lecturio Online Medical Library. Definition. Epidemiology of Hyperkalemia.
Nephrology / Urology Hyperkalemia Causes and Definition Lecturio Online Medical Library See online here Hyperkalemia is defined by the serum potassium level when it is higher than 5.5mEq/L. It is usually
More informationChronic Kidney Disease
Chronic Kidney Disease Chronic Kidney Disease (CKD) Educational Objectives Outline Demographics Propose Strategies to slow progression and improve outcomes Plan for treatment of CKD Chronic Kidney Disease
More informationReducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:
Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital: Eugenio H. Zabaleta, Ph.D. Clinical Chemist OhioHealth Mansfield Hospital Reducing Readmissions and Improving Outcomes at
More information31 days Wed Nov 15, Fri Dec 15, 2017 N/A. Hypoglycemia. Sensor usage (CGM) Mahlon's glucose data was in the target range about 77% of the day.
Mahlon Lovett Overview Report Generated at: Thu, Feb 8, 2018 12:42 PM EST 137 26 N/A 18% 75% 7% Days with CGM data Avg. calibrations per day 3% 1 / 31 0.0 0% Average glucose Standard Hypoglycemia Time
More informationMENTAL CAPACITY ACT POLICY (England & Wales)
Stalbridge Surgery Reviewed June 2017 Next review date June 2018 INTRODUCTION MENTAL CAPACITY ACT POLICY (England & Wales) The Mental Capacity Act (MCA) 2005 became fully effective on 1 st October 2007
More informationFaculty/Presenter Disclosure
CSI for CKD Unravelling the myths surrounding chronic kidney disease Practical Evidence for Informed Practice Oct 21 2016 Dr. Scott Klarenbach University of Alberta Slide 1: Option B (Presenter with NO
More informationABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour
ABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour Dr Indranil Dasgupta Rationale No national practical
More informationMANAGEMENT OF HYPERKALAEMIA
ABC of Intravenous Fluids, Electrolyte Disorders and AKI Management in Adults WASD 6 MANAGEMENT OF HYPERKALAEMIA Hyperkalaemia is a serum potassium concentration (s[k])$5.5mmol/l. It is the most serious
More informationTitle of Guideline (must include the word Guideline Guideline for the Treatment of Hypokalaemia in Adults
Title of Guideline (must include the word Guideline Guideline for the Treatment of (not protocol, policy, procedure etc) Hypokalaemia in Adults Contact Name and Job Title (author) Emily Snow, Pharmacist
More informationGUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES
GUIDELINE FOR THE MANAGEMENT AND PREVENTION OF ACUTE TUMOUR LYSIS SYNDROME IN HAEMATOLOGICAL MALIGNANCIES Full Title of Guideline: Author (include email and role): Division & Speciality: Scope (Target
More informationSouthern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care
Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: Flow Diagram: Recommended response time to AKI warning stage test results for adults in primary care 2 Table
More informationNormal range of serum potassium is meq/l true hyperkalemia manifests clinically as : Clinical presentation : muscle and cardiac dysfunction
Potassium Disorders hyperkalemia Potassium is mainly an cation? What is the major physiological role of potassium in the body? What is the major regulatory system of serum potassium level? Which part of
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,
More informationHarmonisation of Reference Ranges
Harmonisation of Reference Ranges Ken Sikaris BSc(Hons), MBBS, FRCPA, FAACB, FFSc Vice President, AACB (Education) Chemical Pathologist, Melbourne Pathology Director of Clinical Support Systems, Sonic
More informationChronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update)
Chronic heart failure: management of chronic heart failure in adults in primary and secondary care (partial update) NICE guideline Apendix C The algorithms Draft for consultation, January 2010 Chronic
More informationDoncaster & Bassetlaw. AKI guidelines for primary care
Doncaster & Bassetlaw AKI guidelines for primary care Contents: FLOW DIAGRAM: MANAGEMENT OF PATIENTS WITH AKI DETECTED IN PRIMARY CARE... 2 FLOW DIAGRAM: MANAGEMENT OF HYPERKALAEMIA.... 3 FLOW DIAGRAM:
More informationMidMichigan Health LABORATORY POLICY Title: Effecti ve te: Key Words: places: Category: Applicability: reference laboratory
Page 1 of 5 PURPOSE This policy describes the responsibilities for determining which tests performed and or provided by the MidMichigan Health Laboratories fulfill the criteria for critical values / critical
More informationHyperkalemia Protect, Shift, and Eliminate
Disclosure Michael C. Thomas reports no relevant financial relationships. Lytes Off in Vegas! The Acute Management of Potassium and Calcium Disorders Program Objectives Design a plan to replace and monitor
More informationMy Transplant Log. Patient Education. After a kidney/pancreas transplant. Vital Signs
Patient Education Page 20-1 My Transplant Log After a kidney/pancreas transplant This section of the Guide to Your Kidney/Pancreas Transplant explains the tests you will have after your transplant. It
More informationYear 1 Peer Based Learning 2018 Renal System
Please note this learning resource has been produced by the GUMS Academic Team. It is possible that there are some minor errors in the questions/answers, and other possible answers that are not included
More informationUrgent start PD: Putting the person first
Urgent start PD: Putting the person first Arsh Jain MD, FRCPC, MSc ADC 2019 Who can we target with urgent start PD? Late or not referred Early referral Urgent dialysis start HD catheter Facility HD Who
More informationNICE Clinical Guideline 169 Acute Kidney Injury Local Implementation Gap Analysis
NICE Clinical Guideline 169 Acute Kidney Injury Local Implementation Gap Analysis Please tick appropriate box in response to questions below and return to Michelle Timoney (michelle.timoney@nhs.net) by
More informationCase TWO. Vital Signs: Temperature 36.6degC BP 137/89 HR 110 SpO2 97% on Room Air
Mr N is a 64year old Chinese gentleman who is a heavy drinker, still actively drinking, and chronic smoker of >40pack year history. He has a past medical history significant for Hypertension, Hyperlipidemia,
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationDiabetes and Hypertension
Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for
More informationPaediatric reference intervals an update. Tina Yen Harmonisation Workshop Sydney 18 th May 2017
Paediatric reference intervals an update Tina Yen Harmonisation Workshop Sydney 18 th May 2017 Meeting of the AACB Paediatric SIG Tuesday 16 th May 2017 Prof Frank Bowling (NSW/ TAS) Prof Rita Horvath
More informationINTRAVENOUS FLUIDS PRINCIPLES
INTRAVENOUS FLUIDS PRINCIPLES Postnatal physiological weight loss is approximately 5-10% Postnatal diuresis is delayed in Respiratory Distress Syndrome (RDS) Preterm babies have limited capacity to excrete
More informationRicky Bell Renal/ICM Registrar
Ricky Bell Renal/ICM Registrar Objectives When to call renal How to manage the patient with AKI How the manage the patient with CKD (HD/PD) Special AKI situations What do the guidelines say? My referral
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%
More informationSupplement Table 1. Definitions for Causes of Death
Supplement Table 1. Definitions for Causes of Death 3. Cause of Death: To record the primary cause of death. Record only one answer. Classify cause of death as one of the following: 3.1 Cardiac: Death
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationCOMPLIANCE WITH THIS DOCUMENT IS MANDATORY
COVER SHEET `NAME OF DOCUMENT TYPE OF DOCUMENT at Shoalhaven Hospital Group Critical Care Procedure DOCUMENT NUMBER DATE OF PUBLICATION February 2018 RISK RATING Medium REVIEW DATE February 2021 FORMER
More informationAn audit of raised potassium results from GP surgeries in June and December 2017
An audit of raised potassium results from GP surgeries in June and December 2017 Background Potassium is found inside blood cells at concentrations approximately 40-fold higher than outside cells, in the
More informationCardiorenal and Renocardiac Syndrome
And Renocardiac Syndrome A Vicious Cycle Cardiorenal and Renocardiac Syndrome Type 1 (acute) Acute HF results in acute kidney injury Type 2 Chronic cardiac dysfunction (eg, chronic HF) causes progressive
More informationFluid Management in Critically Ill AKI Patients
Fluid Management in Critically Ill AKI Patients Sang Kyung Jo, MD, PhD Department of Internal Medicine Korea University Medical College KO/MG31/15-0017 Outline Fluid balance in critically ill patients:
More informationNarelle Hadlow, Peter Ward, Ken Sikaris
Narelle Hadlow, Peter Ward, Ken Sikaris Analytes for consideration Vascular, renal and Na and water changes Consider physiology and review data Na, K, Cl, Urea, Cr, Osm Acid base status Consider physiology
More informationConcept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA
Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress
More informationVenous Blood Gas Reference Intervals
Venous Blood Gas Reference Intervals The NSW Health Pathology approach Andrea Rita Horvath Department of Clinical Chemistry & Endocrinology NSW Health Pathology, Prince of Wales Hospital, Sydney andrea.horvath@health.nsw.gov.au
More informationDisclosures. Relevant Financial Relationship(s): List or Nothing to Disclose. Off Label Usage: List or Nothing to Disclose 12/9/2016
Staffing to Workload Joy Gomez December 12, 2016 Disclosures Relevant Financial Relationship(s): List or Nothing to Disclose Off Label Usage: List or Nothing to Disclose 1 Objectives Discuss data driven
More informationThe Whats and Hows of Reference Intervals. Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney
The Whats and Hows of Reference Intervals Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney Surabaya Indonesia 2016 Acknowledgements Reference Intervals - Summary What are they
More informationAcute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? Modalities of Dialysis
Acute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? A common condition in ICU patients Associated with high mortality and morbidity Renal Replacement Therapy (RRT) is the cornerstone
More informationThe Failing Heart in Primary Care
The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and
More informationManagement of the patient with established AKI. Kelly Wright Lead Nurse for AKI King s College Hospital
Management of the patient with established AKI Kelly Wright Lead Nurse for AKI King s College Hospital Medical management Medical management Respiratory- pulmonary oedema, repositioning- upright, oxygen
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Potassium Chloride
More informationK+ Ann Crawford, RN, PhD, CNS, CEN
Hyperkalemia: Management of a Critical Electrolyte Disturbance K+ Ann Crawford, RN, PhD, CNS, CEN Balancing Fluid Intracellular fluid (ICF) Extracellular fluid (ECF) Intravascular interstitial Hormonal
More informationCSI (Clinical Scenario Investigation): Hyperkalemia
CSI (Clinical Scenario Investigation): Hyperkalemia Alison Thomas, RN(EC), MN, CNeph(C) Ann Jones, RN(EC), MSN, CNeph(C) Joyce Hunter, RN, Vascular Access Co-ordinator Simcoe Muskoka Regional Kidney Care
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationDiagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter
Diagnostic criteria for diabetes Routine cases and Non-diabetic hyperglycaemia adapted with permission from Royal Devon and Exeter Diabetes may be diagnosed on any of the following criteria (WHO 2006,
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 27 May 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 27 May 2009 CARDENSIEL 1.25 mg, film-coated tablet B/30 (CIP code: 352 968-1) CARDENSIEL 2.5 mg, film-coated tablet
More informationData & Definitions Frequently Asked Questions
Cancer Waiting Times Data & Definitions Frequently sked uestions This document provides questions and answers on data and definitions for Cancer Waiting Times. The references below provide context and
More informationUpdate: Body Fluid Testing. Fernando San Gil
Update: Body Fluid Testing Fernando San Gil Background Notes - 1 Year Significant moments in IVD 2013 NATA and the TGA publish new validation and registration requirements for in-house IVDs and for in-house
More informationRENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University
RENAL FAILURE IN CHILDREN Dr. Mai Mohamed Elhassan Assistant Professor Jazan University OBJECTIVES By the end of this lecture each student should be able to: Define acute & chronic kidney disease(ckd)
More informationSetting of quality standards
Setting of quality standards Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney AACB ASM Adelaide October 2014 Setting of Quality Standards - 2013 The 2013 QC workshop revealed
More informationHypoglycemia, Electrolyte disturbances and acid-base imbalances
Hypoglycemia, Electrolyte disturbances and acid-base imbalances Pediatric emergency PICU division Pediatric department Medical faculty, University of Sumatera Utara H. Adam Malik Hospital 1 Hypoglycemia
More informationGuidelines for the Treatment of
Guidelines for the Treatment of Hyperkalaemia in Adults August 2014 This document is a revision of the original Guidelines for the Treatment of Hyperkalaemia in Adults developed by GAIN in 2009 1 PREFACE
More informationWESTMEAD Cardiac QUESTIONS PRACTICE SAQ
QUESTION 1 A 65-year-old man presents to the emergency department with a history of palpitations. His vital signs are: BP 105/60 mmhg HR 156 beats/min RR 26 /min Temperature 36.2 o C His ECG is on the
More information